If you are not happy with the results below please do another search
Researchers have demonstrated that an optical technique known as Raman spectroscopy can be used to differentiate between benign and cancerous thyroid cells. The new study shows Raman spectroscopy’s potential as a tool to improve the diagnosis of thyroid cancer, which is the ninth most common cancer with more than 50,000 new cases diagnosed in the […]
A team led by Johns Hopkins Kimmel Cancer Center investigators reports that a new laboratory test they developed to identify chemical changes to a group of cancer-related genes can accurately detect which breast tumours are cancerous or benign, and do it in far less time than gold-standard tests on biopsied breast tissue. Although the findings […]
A research team, led by investigators from Georgetown University Medical Center and Fudan University in China, has devised a very promising non-invasive and individualized technique for detecting and treating bladder cancer. The method uses a “liquid biopsy” — a urine specimen — instead of the invasive tumour sampling needed today, and a method developed and […]
Scientists have identified key changes in immune cells within cancerous tumours that could help improve the development of treatments. The study also found a set of genes that are expressed at high levels in breast cancer tumours and linked to more aggressive cancer types. Researchers say the discoveries offer clues to diagnosis and predicting patient […]
A new study confirms the long-suspected role of obesity as a risk factor for developing renal cell carcinoma (RCC), a type of kidney cancer, and identifies several specific obesity-related factors.These factors include multiple measures of obesity, diastolic blood pressure and fasting insulin. In contrast, the study found little evidence for an association with RCC risk […]
New research led by scientists at the Medical Research Council (MRC) Toxicology Unit and University of Leicester suggests that, by analysing levels of tumour-derived DNA in the blood, the early detection of lung cancer could be improved. The study found that, in preliminary tests using mice, a blood test could measure the circulating levels of […]
A City of Hope scientist and his colleagues have developed a user-friendly approach to creating “theranostics” – therapy combined with diagnostics – that target specific tumours and diseases. Key to the process are molecules called metallocorroles, which serve as versatile platforms for the development of drugs and imaging agents. City of Hope’s John Termini, Ph.D., […]
Quo-Lab, an HbA1c analyser, combines high accuracy with low cost, easy to use technology. the analyser has been specifically developed to provide a point-of-care device that meets the needs of clinics and laboratories in countries where diabetes is an increasingly large public health issue and resources are limited, including countries in Asia, Africa and South […]
The Acusera Liquid Cardiac Control is designed with ease of use and convenience in mind. The liquid ready-to-use format eliminates problems with reconstitution making it ideal for both the clinical laboratory and point of care testing. With method and instrument specific target values provided for an impressive 10 cardiac markers including BNP, NT-ProBNP, D-dimer and […]
Two innovative new ELISA systems provide separate detection of the diagnostically relevant antibodies in Bordetella pertussis infections: antibodies against pertussis toxin (PT) and antibodies against filamentous haemagglutinin (FHA). Independent determination of these antibodies is critical to enable a meaningful diagnostic interpretation, as emphasised in recent publications. Determination of IgG antibodies against PT is a front-line […]
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
